Peiling Yang

发表

Some Challenges With Statistical Inference in Adaptive Designs

Sue-Jane Wang, H. M. Hung, Peiling Yang, 2014, Journal of biopharmaceutical statistics.

Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials

Sue-Jane Wang, H. M. Hung, Peiling Yang, 2016, Journal of biopharmaceutical statistics.

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.

N. Khin, Yeh-Fong Chen, Peiling Yang, 2012, The Journal of clinical psychiatry.

CENTER FOR DRUG EVALUATION AND RESEARCH

K. Updegraff, Peiling Yang, 2010 .

Fulvestrant in postmenopausal women with advanced breast cancer.

R. Pazdur, R. Lostritto, Grant A. Williams, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Report from the FDA Fulvestrant in Postmenopausal Women with Advanced Breast Cancer

R. Pazdur, R. Lostritto, Gene M. Williams, 2003 .

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.

E. Unger, R. Temple, A. Jackson, 2015, Journal of Clinical Psychiatry.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

N. Khin, Yeh-Fong Chen, Peiling Yang, 2011, The Journal of clinical psychiatry.

Simultaneous Use of Weighted Logrank and Standardized Kaplan-Meier Statistics

T. Fleming, Peiling Yang, 2006, Journal of biopharmaceutical statistics.

Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration.

Yeh-Fong Chen, Peiling Yang, E. Unger, 2014, The Journal of clinical psychiatry.

DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Peiling Yang, Juliette Toure Hfd, 2009 .

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Sue-Jane Wang, I. Zineh, E. Unger, 2011, The Journal of clinical psychiatry.

Design considerations for handling dropouts in anti-depressant drug trials.

Peiling Yang, J. Zhong, N. A. Khin, 2018, Contemporary clinical trials.

Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study

E. Tai, H. Chua, A. Wong, 2021, Cancers.